These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9177396)

  • 1. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.
    Ain KB; Taylor KD; Tofiq S; Venkataraman G
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1857-62. PubMed ID: 9177396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.
    Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; Vignali C; Margutti A; Bondanelli M; Pansini GC; Pelizzo MR; Culler MD; Degli Uberti EC
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2218-24. PubMed ID: 16569735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers.
    Carmona Matos DM; Jang S; Hijaz B; Chang AW; Lloyd RV; Chen H; Jaskula-Sztul R
    Surgery; 2019 Jan; 165(1):64-68. PubMed ID: 30415874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
    Forssell-Aronsson EB; Nilsson O; Bejegård SA; Kölby L; Bernhardt P; Mölne J; Hashemi SH; Wängberg B; Tisell LE; Ahlman H
    J Nucl Med; 2000 Apr; 41(4):636-42. PubMed ID: 10768564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro.
    Ain KB; Taylor KD
    J Clin Endocrinol Metab; 1994 May; 78(5):1097-102. PubMed ID: 7909817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor subtype expression in human thyroid tumours.
    Klagge A; Krause K; Schierle K; Steinert F; Dralle H; Fuhrer D
    Horm Metab Res; 2010 Apr; 42(4):237-40. PubMed ID: 20094970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin.
    Cassoni P; Muccioli G; Marrocco T; Volante M; Allia E; Ghigo E; Deghenghi R; Papotti M
    J Endocrinol Invest; 2002 Apr; 25(4):362-8. PubMed ID: 12030609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
    Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
    Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
    Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
    J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
    Reubi JC; Schaer JC; Waser B; Mengod G
    Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.
    Elisei R; Vivaldi A; Agate L; Ciampi R; Molinaro E; Piampiani P; Romei C; Faviana P; Basolo F; Miccoli P; Capodanno A; Collecchi P; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2403-11. PubMed ID: 15623821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression patterns of somatostatin receptor subtypes in cultured epithelial cells from human normal prostate and prostate cancer.
    Sinisi AA; Bellastella A; Prezioso D; Nicchio MR; Lotti T; Salvatore M; Pasquali D
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2566-9. PubMed ID: 9253335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
    Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
    Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
    Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
    J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin receptors in differentiated thyroid tumors: restricted expression of the 67-kilodalton laminin receptor in follicular carcinoma cells.
    Montuori N; Müller F; De Riu S; Fenzi G; Sobel ME; Rossi G; Vitale M
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2086-92. PubMed ID: 10372715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells.
    Bruno JF; Xu Y; Berelowitz M
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1738-43. PubMed ID: 7914724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomas.
    Jaquet P; Ouafik L; Saveanu A; Gunz G; Fina F; Dufour H; Culler MD; Moreau JP; Enjalbert A
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3268-76. PubMed ID: 10487698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen and somatostatin analogue on growth of human medullary, follicular, and papillary thyroid carcinoma cell lines: tissue culture and nude mouse xenograft studies.
    Weber CJ; Marvin M; Krekun S; Koschitzky T; Karp F; Benson M; Feind CR
    Surgery; 1990 Dec; 108(6):1065-71. PubMed ID: 1978945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat.
    Bruno JF; Xu Y; Song J; Berelowitz M
    Endocrinology; 1993 Dec; 133(6):2561-7. PubMed ID: 8243278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.